Truist Securities Initiates Coverage On Biomea Fusion with Buy Rating, Announces Price Target of $55
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Robyn Karnauskas initiates coverage on Biomea Fusion (NASDAQ:BMEA) with a Buy rating and a price target of $55.
February 06, 2024 | 1:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities has initiated coverage on Biomea Fusion with a Buy rating and set a price target of $55.
The initiation of coverage by Truist Securities with a Buy rating and a high price target of $55 is a strong positive signal for Biomea Fusion. This endorsement from a reputable analyst could lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100